NF-κB transcription factors also activate TAMs in the tumour stroma to secrete inflammatory cytokines, which suppresses dendritic cells (DCs) maturation and inhibits the adaptive immune response necessary for tumour rejection. The gene discussed is NFKB1; the disease is neoplasm.